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Abstract Multiple sclerosis (MS) is characterized by
episodes of inflammatory demyelination with progressive
failure of remyelination. Prior studies using murine models
of MS indicate that remyelination within the adult central
nervous system (CNS) requires the expression and activity
of TNFR2 and CXCR4 by oligodendrocyte progenitor cells
(OPCs), promoting their proliferation and differentiation
into mature oligodendrocytes. Here, we extend these
studies by examining the role of TNFR2 in the expression
of the CXCR4 ligand, CXCL12, within the corpus callo-
sum (CC) during cuprizone (CPZ) intoxication and by
demonstrating that lentiviral-mediated gene delivery of
CXCL12 to the demyelinated CC improves OPC prolifer-
ation and myelin expression during remyelination.
Activated astrocytes and microglia express both TNFR1
and TNFR2 within the demyelinated CC. However, CPZ
intoxicated TNFR2-/- mice exhibit loss of up-regulation
of CXCL12 in astrocytes with concomitant decreases in
numbers of CXCR4? NG2? OPCs within the CC. While
CXCR4 antagonism does not affect OPC migration from
subventricular zones into the CC, it decreases their pro-
liferation and differentiation within the CC. Stereotactic
delivery of lentivirus expressing CXCL12 protein into the
CC of acutely demyelinated TNFR2-/- mice increases
OPC proliferation and expression of myelin. In contrast,
chronically demyelinated wild-type mice, which exhibit
significant loss of astrocytes and OPCs, are unable to be
rescued via CXCL12 lentivirus alone but instead required
engraftment of CXCL12-expressing astrocytes for
increased myelin expression. Our results show that TNFR2
activation induces CXCL12 expression in the demyelinated
CC via autocrine signaling specifically within astrocytes,
which promotes OPC proliferation and differentiation. In
addition, gene delivery of critical pro-myelinating proteins
might be a feasible approach for the treatment of remye-
lination failure in MS.
Introduction
Multiple sclerosis (MS) is an inflammatory, demyelinating
disease of the central nervous system (CNS) that presents
most often in a relapsing/remitting form, in which a period
of demyelination is followed by a period of functional
recovery [8, 56]. The recovery stage involves the generation
of new myelinating oligodendrocytes, but as the disease
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worsens, patients exhibit less recovery and accumulate
neurological deficits leading to progressive disability.
Neurologic functional impairment has been correlated with
axonal injury and degeneration, which may occur as a result
of remyelination failure or the direct effects of inflamma-
tion. While inflammation and remyelination are distinct
processes, they are each regulated by master cytokines, such
as tumor necrosis factor (TNF-a), that differentially impact
infiltrating immune cells and repair of myelin injury. Thus,
while successful targeting of TNF-a has led to effective
treatments for peripheral autoimmune diseases such as
rheumatoid arthritis, psoriasis and inflammatory bowel
disease [24, 27, 40], targeting TNF-a in MS patients via
administration of a recombinant TNF receptor p55 immu-
noglobulin fusion protein (lenercept) increased frequency,
duration, and severity of MS exacerbations [21], revealing
critical roles for this molecule in recovery.
TNF-a is a pleiotropic cytokine that signals through
TNFR1 and TNFR2, inducing apoptotic (TNFR1) and sur-
vival pathways (TNFR1 and TNFR2) [4, 40]. MS patients
exhibit high levels of TNF-a in cerebrospinal fluid and
serum, which are positively correlated with lesion severity
[23, 31]. In addition, administration of anti-TNF-a agents or
use of mice with targeted deletion of TNFR1 in the murine
model of MS, experimental autoimmune encephalitis
(EAE), revealed a critical role for this receptor in induction
of inflammation [17]. Studies examining the roles of TNF-a
receptors in remyelination using a model of demyelination
within the adult corpus callosum (CC) induced by the copper
chelator cuprizone (CPZ), showed that TNFR2 activity is
critical for the proliferation and differentiation of OPCs,
resulting in attenuation of remyelination after cessation of
CPZ [2]. These data suggest that TNFR2 plays a role in CNS
repair of myelin and explain the failure of anti-TNF-a
agents to alleviate disease in MS patients.
While the mechanism of TNF-a-mediated remyelination
is not known, numerous studies indicate that it induces the
expression of the chemokine CXCL12 in various cell types
within the CNS [1, 22, 25]. CXCL12 is a pivotal regulator of
both leukocyte CNS entry and oligodendrocyte differentia-
tion in the adult CNS [36, 37, 43]. CXCL12 is expressed
along vascular ablumina and by activated astrocytes and
microglia, leading, respectively, to the perivascular locali-
zation of infiltrating leukocytes and to the recruitment and
maturation of oligodendrocyte progenitor cells (OPCs),
which both express the CXCL12 receptor, CXCR4 [36, 37,
43]. Demyelination in the context of CPZ exposure led to
increased expression of CXCL12 within the CC. Addition-
ally, loss of CXCR4 signaling, via pharmacological
antagonism or RNA silencing, prevented the maturation of
OPCs at this site [43]. In addition, prolonged exposure to
CPZ, which leads to chronic demyelination, was associated
with lack of CXCL12 up-regulation within the CC [43].
These data led us to hypothesize that remyelination failure in
TNFR2-deficient mice was similarly linked to loss of
CXCL12 expression. Here we report that TNFR2-deficient
mice exhibit lack of up-regulation of CXCL12 within acti-
vated astrocytes and lower numbers of CXCR4? OPCs
within the CC during CPZ-induced demyelination. BrDU-
labeling studies revealed a role for CXCR4 in the prolifer-
ation of NG2? OPCs within the demyelinated CC.
Stereotactic delivery of lentivirus expressing CXCL12 into
the CC of acutely demyelinated, TNFR2-deficient mice
promoted OPC proliferation and myelin expression. In
contrast, mice with chronically demyelinated CC due to
prolonged CPZ exposure, which display reduced up-regu-
lation of CXCL12 and decreased numbers of activated
astrocytes and OPCs, exhibit lack of remyelination rescue in
response to lentiviral delivery of CXCL12. These data
identify a critical role for TNFR2? astrocytes in CXCL12-
mediated remyelination and demonstrate that gene delivery
approaches may ameliorate failed remyelination.
Materials and methods
Animals
TNFR1-/-, TNFR2-/- and C57BL/6 control mice were
purchased from Jackson Laboratories (Bar Harbor, ME).
Breeder colonies of TNFR1-/-, TNFR2-/-, TNFR1,2-/-
were maintained at Washington University. All animal
procedures were conducted in compliance with NIH
guidelines for the use of laboratory animals and were
approved by the Animal Studies Committee of Washington
University.
Mouse model of cuprizone-induced demyelination
8- to 10-week old adult male C57BL/6 and TNFR2-/- mice
were fed ad libitum 0.2 % CPZ (Harlan Teklan, Madison,
WI) mixed in standard rodent chow for 4-12 weeks to
induce demyelination of the CC. CPZ-supplemented feed
was removed and mice were fed a standard chow diet to
induce remyelination [43].
Antibodies
The following antibodies were used in this study: CXCL12
rabbit polyclonal (eBioscience, San Diego, CA); CXCR4
rat polyclonal (eBioscience); GFAP rat monoclonal
(Invitrogen, Carlsbad, CA); IBA1 goat polyclonal (Abcam,
Cambridge, MA); MBP rat monoclonal (Abcam); TNFR1
rabbit polyclonal (Abcam); TNFR2 goat polyclonal (R&D
systems, Minneapolils, MN); MOG rat monoclonal (R&D
systems); BRDU mouse monoclonal (Sigma, St Louis,
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MO); NG2 rabbit polyclonal (Millipore, Billerica, MA),
PDGFRa rat monoclonal (Millipore) and rabbit dsRed for
detection of mCherry (Biovision, Milpitas, CA).
Immunohistochemistry
Mice were intracardially perfused with 4 % paraformalde-
hyde (PFA) prior to harvest of the brain, which was post fixed
overnight in 4 % PFA, cryoprotected in 20 % sucrose, and
embedded in frozen medium for sectioning. For immuno-
detection of chemokine, chemokine and cytokine receptors,
cell markers and mCherry, tissue sections were blocked with
appropriate concentrations of goat or donkey serum and
triton x and then exposed to primary antibody overnight at
4 C. Slides were washed in PBS followed by incubation of
secondary antibodies for 60 min at room temperature. After
washing in PBS, slides were nuclear stained with ToPro-3
(Invitrogen) and coverslip were applied with Prolong Gold
(Invitrogen) before being visualized on the Zeiss LSM 510
META Confocal Laser Scanning Microscope (Carl Zeiss
International, Jena, Germany). Measurement of positive
immunofluorescent signals was accomplished using Voloc-
ity (Improvision Waltham, MA, USA) or the public domain
NIH Image program ImageJ.
Image analysis
When comparing different treatments (PBS versus
AMD3100 or empty vector versus CXCL12 expressing
lentivirus) and genotypes (wild-type versus TNFR2-defi-
cient mice) all images were taken at the same exposure
settings. To determine the area of double positive labeling,
threshold parameters were determined using both the
negative controls (isotype control) and images with the
lowest fluorescent intensity in both the red and green
channels to set the lower threshold setting. Upper threshold
settings were not set. The Volocity program was used to
determine the area of double labeling and ImageJ was used
to determine intensity of signal.
In vivo AMD3100 treatment
AMD3100 treatment was performed as previously published
[36]. Briefly, 28-day osmotic pumps with an infusion rate of
0.11 ll/h (Alzet), containing AMD3100 (40 mg/ml) or
vehicle (PBS), were implanted subcutaneously into the
flanks of mice at the start of CPZ ingestion for proliferation
studies or after 7 days after CPZ start for recruitment studies.
In vivo bromodeoxyuridine incorporation
Bromodeoxyuridine (BrDU; Sigma) incorporation experi-
ments were performed as previously described [43].
Briefly, BrDU (50–100 mg/kg) was injected into the peri-
toneal cavity of experimental mice every 8 h for 4 days.
For baseline levels of dividing OPCs and for OPC prolif-
eration experiments, mice were injected in this fashion for
4 days prior to killing whereas OPC migration experiments
required killing 3 weeks after BrDU exposure.
Lentivirus
All lentiviruses were produced by the Viral Vectors Core
Facility of the Hope Center for Neurological Diseases at
Washington University School of Medicine. Murine
CXCL12 lentivirus vector (FUW-C) and a second vector
encoding mCherry protein alone were generated as previ-
ously described [50].
In vivo lentiviral delivery
Delivery of CXCL12 mCherry versus mCherry express-
ing lentivirus to the CC was accomplished as previously
described [43]. Briefly, mice (groups of 3–5) were
anesthetized, positioned in a stereotaxic apparatus and a
small incision was made to the scalp [43]. The lateral CC
was marked using the following coordinates relative to
Bregma: anterior–posterior -2, medial–lateral ?0.5, and
dorsal–ventral -1.2 [44]. Two microliters of lentivirus
were injected using a nanoinjector pump (Stoelting,
Wood Dale, IL) into the mouse at a rate of 0.2 ll per
min. The mice continued on CPZ feed for 5 days after
injection to ensure viral infection. Mice were later swit-
ched to standard chow for 10 days before evaluation of
CNS tissue.
In vivo engraftment
Postnatal astroblasts were cultured from 3-day-old wild-
type mouse pups as previously described [43]. After 4 days
in culture, the cells were infected with either the CXCL12
mCherry versus mCherry expressing lentivirus for 3 days.
The cells were enzymatically detached and 60,000 cells
were injected into the CC at the same coordinates as the
lentivirus injection experiments. The mice continued on
CPZ feed for 5 days after injection to ensure viral infec-
tion. Mice were later switched to standard chow for
10 days before evaluation of CNS tissue.
Statistical analyses
Data were analyzed using Prism software (GraphPad
Software). The Student’s t test was used to determine the
statistical significance of immunohistochemistry data.
P \ 0.05 was considered to be significant.
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Results
TNFR2 mediates expression of CXCL12
within activated astrocytes during CPZ-induced
demyelination
In published studies, astrocytes and microglia within the de-
myelinated CC of mice exposed to CPZ exhibited increased
expression of TNF-a, and activation of TNFR2 proved
essential for remyelination upon cessation of toxin. In order to
address the mechanism of TNFR2-mediated remyelination,
we first identified cellular targets of TNF-a within the CC of
naı¨ve and CPZ-demyelinated wild-type mice. Quantitative
confocal IHC detection of TNFR1 and TNFR2 in astrocytes
(GFAP), microglia (IBA-1) and OPCs (PDGFRa) within the
CC was performed on CNS tissues derived from 8-week-old
naı¨ve C57BL/6 mice (Supp Figure 1) and from those exposed
to CPZ for 6 weeks (Fig. 1). Quantitative confocal IHC
revealed high levels of expression of both TNFR1 and
TNFR2 by activated astrocytes while microglia expressed
much lower levels of both receptors (Fig. 1). OPCs within the
demyelinated CC expressed higher levels of TNFR2 than
TNFR1 (Fig. 1) (P = 0.008), while neither receptor was
expressed by any cell type in the CC of naı¨ve mice (Supp
Figure 1). Because TNFR2-/-, and not TNFR1-/-, mice
exhibited impaired proliferation and maturation of OPCs in
the context of CPZ toxicity [2], we wondered whether these
receptors differentially impacted the expression of chemo-
kines previously shown to influence the remyelinating
capabilities of OPCs [11, 12, 18, 30, 42, 55]. Dissected CC
from CPZ-exposed, wild-type mice exhibited increased
expression of CXCL1, CXCL2, and CXCL12 mRNAs
compared with naı¨ve controls, while those from TNFR2-
deficient mice expressed lower levels of CXCL1 (P = 0.042)
and CXCL12 (P = 0.043) (Fig. 2a–c), as assessed via
quantitative RT-PCR (QPCR). Quantitative confocal analysis
of CXCL12 protein expression within GFAP? cells of the
caudal CC after 6 weeks of CPZ exposure revealed it was
significantly decreased in TNFR2-/- mice compared with
similarly exposed wild-type animals (Fig. 2d–f) (P = 0.011).
In contrast, IBA1? cells within the CC of CPZ-exposed
TNFR2-deficient mice exhibited similar levels of CXCL12
expression as wild-type animals (Fig. 2g–i) (P = 0.113).
Taken altogether, these data indicate that TNFR2 is required
for expression of CXCL12 specifically by activated astro-
cytes within the CC during CPZ-induced demyelination.
TNFR2-deficient mice exhibit reduced numbers
of CXCR4? OPCs in the CC during CPZ exposure
Expression of CXCL12 within the demyelinated, caudal CC
has previously been shown to be critical for OPC maturation
during remyelination via activation of CXCR4, which is
expressed by NG2? OPCs [43]. These studies, however, did
not identify a role for CXCR4 in OPC migration or early
proliferation in the context of CPZ toxicity. Because prior
studies also determined that TNFR2 activity is required for
proliferation of OPCs within the CC during CPZ exposure [2],
we hypothesized that impaired remyelination in TNFR2-
deficient mice might be due to loss of CXCL12-mediated
activation of CXCR4 in OPCs. Indeed, TNFR2-/- mice
exposed to CPZ for 6 weeks exhibit significantly decreased
numbers of CXCR4? NG2? OPCs compared with similarly
exposed wild-type controls (Fig. 3a, b) (P = 7.83 9 10-7).
To determine whether CXCR4 activation mediates prolifer-
ation of OPCs in the SVZ and the CC during CPZ exposure,
we performed BrDU labeling studies in wild-type mice in
combination with treatment with the specific CXCR4 antag-
onist, AMD3100, versus phosphate buffered saline (PBS)
vehicle [43]. Baseline BrDU incorporation within OPCs was
established by injecting mice with BrDU for four consecutive
days beginning at the initiation of CPZ exposure (Fig. 3d).
The effect of CXCR4 activation on OPC proliferation was
determined via BrDU labeling of OPCs after three weeks of
continuous administration of AMD3100 or PBS during CPZ
exposure (Fig. 3e). As expected, the CC of mice that were
treated with PBS had an expanded population of BrDU?
NG2? cells, as detected by quantitative confocal IHC, com-
pared to baseline which was significantly decreased in the CC
of mice treated with AMD3100 (Fig. 3f–i) (P = 0.007). In
contrast, proliferation of NG2? cells in the SVZ was unaf-
fected by CXCR4 antagonism (Fig. 3j–m) (P = 0.7884).
These data suggest that CXCR4 activation is required for the
initial proliferation of OPCs within the demyelinated CC. To
determine whether CXCR4-mediated recruitment of OPCs to
the CC contributes to the expanded population of NG2? cells,
we used BrDU-labeling to follow OPCs in their migration
from the SVZ into the CC in CPZ-exposed mice treated with
CXCR4 antagonist. Baseline BrDU labeling was performed
in control mice that were exposed to CPZ for 4 days followed
by BrDU injections for four additional days while continuing
CPZ ingestion (Suppl Figure 2a). AMD3100-or PBS treat-
ment was initiated after BrDU injections and continued along
with CPZ exposure for 3 weeks (Supp Figure 2a). Quantita-
tion of total numbers of BrDU? NG2? cells within the SVZ
and CC prior to AMD3100 or PBS treatment revealed no
differences in either brain region (Sup Figure 2i). Taken
together, these data indicate that CXCR4 is necessary for OPC
proliferation within the demyelinated CC but not for the
migration of these cells from the SVZ.
Delivery of CXCL12-encoding lentivirus rescues
remyelination
We and others have shown that CXCL12 is required to
promote remyelination of the injured adult CNS [10–12].
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Given that TNFR2-deficient mice exhibit lack of CXCL12
up-regulation within astrocytes of the demyelinated CC
(Fig. 2f), we wondered whether reinstating CXCL12
expression at this site might rescue the delayed remyeli-
nation observed in TNFR2-/- mice. Two lentiviral
constructs were used to test this hypothesis, one encoding-
CXCL12 and mCherry and another encoding mCherry
alone [50]. In vitro infection of astrocytes with lentivirus
encoding both CXCL12 and mCherry confirmed trans-
duction and CXCL12 expression as assessed by
immunocytochemistry (Fig. 4a–d). After stereotactic
injection of either lentivirus into the CC of CPZ-exposed
wild-type or TNFR2-/- mice, mCherry-expression could
be detected in the CC in either genotype within 10 days
(Fig. 4e, f). Quantitative confocal IHC detection of
CXCL12 protein, however, revealed it was significantly
Fig. 1 Target cells for TNF-a in demyelinating CC. Wild-type mice
were fed a diet containing 0.2 % cuprizone for 6 weeks and then
perfused with 4 % PFA. Sections of the CC were stained for GFAP
(green) (a, b), IBA1 (green) (d, e), PDGFRa (green) (g, h), and
TNFR1 (left, red) and TNFR2 (right, red). Nuclei were counter-
stained with ToPro (blue). TNFR1-/- (left) and TNFR2-/- (right)
mice after 6 weeks of CPZ ingestion were labeled as negative
controls. Images (n = 6–8) were taken of three coronal sections from
3 to 5 mice/group using quantitative confocal IHC over two
independent experiments. Representative images are shown, IC
isotype control. Scale bar 10 lm. (c, f, and i) The mean area of
GFAP ? (c), IBA1? (f), and PDGFRa? (i) cells that express TNFR1
or TNFR2 within the CC in wild-type mice after 6 weeks of CPZ
exposure was quantified. **P \ 0.01
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increased within the CC of mice that received CXCL12-
expressing lentivirus compared with those that received
empty vector lentivirus (Fig. 4g, h) (P = 0.0131).
To determine whether reinstating CXCL12 in the CC of
CPZ-exposed, TNFR2-deficient mice would alter oligo-
dendrocyte biology and remyelination, we examined OPC
proliferation and myelin protein expression within the CC of
lentivirus-infected mice via quantitative confocal IHC.
TNFR2-deficient mice that received CXCL12-encoding
lentivirus exhibited increased numbers of Ki-67?
PDGFRa? OPCs (Fig. 5a–c) (P = 0.008) compared with
those that received empty vector lentivirus. Mice injected
with CXCL12-encoding lentivirus also exhibited a signifi-
cant increase in MBP expression compared with mice
injected with nonspecific lentivirus (Fig. 5d–f) (P = 0.003).
These data indicate that CXCL12 reinstatement can improve
remyelination in TNFR2-deficient mice with CPZ-induced
demyelination.
Prolonged CPZ exposure beyond 12 weeks leads to
chronic demyelination that persists following CPZ cessa-
tion [35]. Given that remyelination was rescued in TNFR2-
deficient mice after CXCL12 reinstatement, we wondered
whether CXCL12 lentivirus might similarly promote re-
myelination in chronically demyelinated mice. CXCL12-
encoding or empty vector lentiviruses were stereotactically
injected into the CC of wild-type mice after 12 weeks of
CPZ exposure. CXCL12 protein expression at 10 days after
both CPZ cessation and lentiviral infection was signifi-
cantly increased within the CC of chronically demyelinated
mice that received CXCL12 compared to those that
received empty vector virus (Fig. 6a–c) (P = 0.003).
Quantitative confocal IHC evaluation of MBP expression in
Fig. 2 Down-regulated
CXCL12 expression in the
demyelinated CC of mice
lacking TNFR2. Wild-type and
TNFR2-/- mice were fed a
0.2 % CPZ-infused diet for
6 weeks. Whole CC was
dissected from wild-type and
TNFR2-/- mice and qRT-PCR
analysis of a CXCL1,
b CXCL2, and c CXCL12
expression was performed
(n = 5 mice/group). Confocal
IHC analysis of CC from wild-
type and TNFR2-/- mice after
6 weeks of CPZ ingestion.
Sections of the CC from (d,
g) wild-type and (e,
h) TNFR2-/- mice were
stained for (d, e) GFAP (green)
and CXCL12 (red) and (g,
h) CXCL12 (green) and IBA1
(red). All nuclei were
counterstained with ToPro
(blue). Representative images
are shown for three coronal
sections from three to five mice
in two separate experiments, IC
isotype control. Scale bars
10 lm. The mean area of
GFAP? (f) and IBA1? (i) cells
that express CXCL12 within the
CC in wild-type (white bars)
and TNFR2-/- mice (black
bars) after 6 weeks of CPZ
exposure was quantified; n = 6
images taken from three to five
mice/group. *P \ 0.05,
***P \ 0.001
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lentivirus-infected CC, however, did not reveal any dif-
ferences between CXCL12 and empty vector viruses
(Fig. 6d–f) (P = 0.24). Of interest, GFAP? astrocytes
(P = 0.0119) and NG2? (P = 0.0118) cell numbers were
significantly decreased in the CC derived from mice
exposed to CPZ for 12 weeks when compared with the CC
of mice fed CPZ for 6 weeks (Fig. 6g–l), suggesting that
lack of astrocyte targets for lentivirus infection or sufficient
OPC numbers to respond to CXCL12 expression prevented
remyelination rescue.
Given these data, we wondered whether engraftment of
CC with astrocytes infected with mCherry and CXCL12-
encoding lentivirus would provide the necessary astrocytes
to rescue remyelination. Postnatal astroblasts infected with
mCherry and CXCL12-encoding or empty vector lentivi-
ruses were stereotactically injected into the CC of wild-
Fig. 3 TNFR2 promotes CXCR4-mediated proliferation of OPCs in
the demyelinated CC. a WT C57Bl/6 and b TNFR2-/- mice were
fed a diet containing 0.2 % CPZ for 6 weeks and then perfused with
4 % PFA. Cryopreserved sections were stained for CXCR4 (green)
and NG2 (red) Abs. Nuclei were counterstained with Topro (blue).
c The number of CXCR4? NG2? cells in the CC was quantified. The
depicted timelines represent the experimental design for the d baseline
and e AMD3100- and vehicle-treated mice. Baseline, PBS- and
AMD-treated mice were perfused with 4 % PFA and cryopreserved
sections of the f–h SVZ and j–l CC were stained for BrDU (green)
and NG2 (red) Abs. Nuclei were counterstained with Topro (blue).
The mean number of BrDU? NG2? cells in the i SVZ and m CC was
quantified
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type mice after 12 weeks of CPZ exposure. Quantitative
confocal IHC evaluation of MBP or MOG expression per
area of GFAP? mCherry? cells in CC revealed increased
expression of MBP (Fig. 6m–o) in the mice engrafted with
astrocytes infected with CXCL12-encoding lentivirus ver-
sus those receiving astroblasts infected with empty vector
virus. These data indicate that engraftment of CXCL12-
expressing astrocytes can improve remyelination in the
chronically demyelinated mice.
Discussion
While the exact mechanisms of remyelination in the adult
CNS are unknown, numerous studies suggest that astrocyte
reactivity is positively correlated with endogenous repair of
myelin [7, 16, 38]. Astrocytes respond to inflammatory
cytokines by secreting growth factors and chemokines that
are known to impact OPC biology [5, 28, 33, 34, 41, 43].
Although it is well-established that TNF-a induces
CXCL12 expression, it is not known which receptor is
responsible for this induction. TNFR2 signaling activates
prosurvival pathways through the recruitment of TRAF2
adapter proteins and subsequent activation of NFjB, which
is known to induce chemokine genes [9, 13]. In spleno-
cytes, NFjB p52/RelB heterodimers induce CXCL12
transcription [26]. Consistent with this, our data indicate
that activated astrocytes express TNFR2, which promotes
OPC proliferation and differentiation via induction of the
chemokine CXCL12. We show that mice fed the
Fig. 4 Lentiviral delivery of CXCL12 to the demyelinated CC of
TNFR2-/- mice. TNFR2-/- mice were fed a diet containing 0.2 %
CPZ for 6 weeks and then a lentivirus containing an empty vector or
CXCL12-expressing vector was stereotactically injected into the CC.
Mice remained on a CPZ-infused diet for 5 days following injection.
The CNS of injected mice was analyzed following a 10-day period on
standard chow. a Fluorescent IHC analysis of CXCL12 (green) and
mCherry (red) expression by primary astrocytes infected with
CXCL12 encoding lentivirus at a 0, b 10, and c 100 MOI. Lower
power images depicting stereotactic injection into CC of TNFR2-/-
mice with mCherry-expressing lentiviruses encoding d empty vector
and e CXCL12 protein are shown. Dotted lines depict the CC.
Confocal IHC analysis of CC was performed on lentivirus-injected
mice. Images depict g, h CXCL12 (green) expression. Nuclei were
counterstained with ToPro (blue). Representative images are shown
for three coronal sections from three to six mice in two separate
experiments. IC isotype control. Scale bars 10 lm. The mean
intensity of CXCL12 expression (i), within the CC of TNFR2-/-
mice injected with the empty vector (white bars) and CXCL12 (black
bars) lentivirus after 6 weeks of CPZ exposure was quantified; n = 6
images were taken from three to six mice/group. *P \ 0.05
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demyelinating intoxicant CPZ display increased expression
of both TNFR1 and TNFR2 by activated astrocytes within
the CC. TNFR2-/- mice, however, which exhibit delayed
remyelination after CPZ cessation [2], show reduced up-
regulation of astrocyte CXCL12 expression within the CC
compared with wild-type animals. Accordingly, reduced
numbers of CXCR4 ? OPCs were observed within the CC
of TNFR2-deficient mice during CPZ-induced demyelina-
tion. BrDU-labeling studies in mice treated with a CXCR4
antagonist during CPZ exposure revealed decreased pro-
liferation, but not migration, of OPCs within the CC when
compared with vehicle-treated controls, suggesting that
CXCL12 acts primarily within the demyelinated CC to
induce the proliferation of recruited OPCs. In support of
this, lentiviral delivery of CXCL12 expression to the CC of
CPZ exposed, TNFR2-deficient mice enhanced OPC pro-
liferation and cell numbers, leading to increased expression
of myelin compared with mice that received empty vector
lentivirus. In contrast, chronically demyelinated CC, which
exhibit decreased astrocyte and OPC numbers, do not
display remyelination rescue in response to CXCL12
lentivirus. These data indicate that TNF-a expression by
the demyelinated CC induces repair via astrocyte expres-
sion of chemokines that target OPCs (Fig. 7).
The role of TNF-a in the pathogenesis of CNS auto-
immunity is unclear. In studies utilizing the murine MS
model, EAE, both TNF-a- and TNFR1-deficient mice are
resistant to disease and the use of anti-TNF or sTNF
receptor antibodies reduced disease severity [17, 46, 47]. In
addition, transgenic mice that over-express TNF-a spon-
taneously develop chronic, inflammatory demyelinating
disease [45]. In human studies, the detection of TNF-a in
both the cerebrospinal fluid of MS patients and within MS
brain lesions [48] also suggested it might be targeted to
ameliorate disease. However, Phase II clinical trials in
which patients with relapsing-remitting MS were admin-
istered Lenercept, a sTNF-RI fusion protein that neutralizes
TNF-a were halted when disease acutely worsened [21].
The ineffectiveness of anti-TNF-a therapy in humans,
contrary to animal studies, suggested divergent roles for
TNF-a receptors in inflammation and repair. Both TNFR1
and TNFR2 can exhibit neuroprotective effects. For
Fig. 5 Lentiviral delivery of CXCL12 rescues remyelination in
TNFR2-/- mice. The CC of TNFR2-/- mice after 6 weeks of CPZ
followed by stereotactic injection with mCherry-expressing lentivi-
ruses encoding empty vector (left) and CXCL12 (right) protein was
analyzed via quantitative confocal IHC. Images depict mCherry
expression (red) with staining for (a, b) Ki-67 (green) PDGFRa (red)
and (d, e) MBP (green). Nuclei are counterstained with ToPro or
DAPI (blue). Representative images shown for three coronal sections
from three to six mice in two separate experiments. IC isotype
control. Scale bars 10 lm. The number of PDGFR? Ki-67? cells (c),
and intensity of MBP expression (f) within the CC of empty vector
(white bars) and CXCL12 (black bars) lentivirus-infected mice was
quantified; n = 6 images taken from three to six mice/group.
*P \ 0.05, **P \ 0.01
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example TNFR1 has been shown to protect neurons against
excitotoxicity by sensitizing the neurons to erythropoietin
and vascular endothelial growth factor (VEGF) and TNFR1
signaling can also activate NFjB which induces prosur-
vival genes [32, 51]. Under certain conditions TNFR1
signaling may activate neuroprotective mechanisms.
However, the predominant signaling pathway is not neu-
roprotective but instead leads to apoptosis [4]. In contrast,
TNFR2 signaling is predominantly neuroprotective as
shown by the use of TNFR2-selective agonist that rescues
neurons from oxidative stress-induced cell death [15].
Consistent with this, TNFR2-deficient mice exhibit delayed
repair in models of remyelination [2] and targeted deletion
of tumor necrosis factor receptor associate-factor 4
(TRAF4), a major signal transducer for TNF-a led to
ultrastructure perturbation in myelin [6]. These data sug-
gest that therapeutic strategies that antagonize TNFR1 to
limit inflammation and augment TNFR2 signaling to
enhance remyelination might provide effective treatments
that both ameliorate disease and promote recovery in MS
patients.
Our results demonstrated that during CPZ-induced
demyelination, OPCs express TNFR2 in greater numbers
than TNFR1. However, TNFR2-deficiency results in lower
numbers of CXCR4? OPCs within CC after demyelina-
tion, suggesting that TNFR2 signaling impacts OPC
biology. We and others previously reported that CXCR4
signaling in OPCs is required for their differentiation into
myelinating oligodendrocytes in murine models of demy-
elination [11, 43]. Studies using the CPZ model of
demyelination, however, did not address the role of
CXCR4 in the recruitment of OPCs from the SVZ. In our
current study, we determined that CXCR4 signaling is
required for proliferation of OPCs within the CC during
demyelination but not for the migration of OPCs to this
site. Thus, the localized demyelination of the CC and
expression of CXCL12 by astrocytes initiates proliferation
of OPCs via CXCR4 signaling directly at the site of the
injury. The migration of OPCs from the SVZ is not directed
by CXCL12, but instead maybe directed by other
Fig. 6 Enhanced CXCL12 expression does not rescue remyelination
following chronic demyelination. Wild-type mice were fed a diet
containing 0.2 % CPZ for 12 weeks and then the CC were injected
with mCherry-expressing lentiviruses encoding empty vector (left)
and CXCL12 (right) protein. Quantitative confocal IHC was used to
analyze the CC 10 days after the cessation of CPZ and stereotactic
lentiviral injections. Images depict mCherry expression (red) with
staining for (a, b) CXCL12 (green) and (d, e) MBP (green). Nuclei
are counterstained with ToPro (blue). Inset depicts MBP staining in
naı¨ve CC as a positive control. Representative images are shown for
three coronal sections from three to six mice in two separate
experiments. IC isotype control. Scale bars 10 lm. The area of
CXCL12? cells (c) and intensity of MBP expression (f) within the
CC of empty vector (white bars) and CXCL12 (black bars) lentivirus-
infected mice was quantified. **P \ 0.01. Wild-type mice were fed a
diet containing 0.2 % CPZ for 6 weeks (left) or 12 weeks (right) and
the CC were then analyzed using quantitative confocal IHC. Sections
of CC were stained for (g, h) GFAP (green) or (j, k) NG2 (red) and
nuclei were counterstained with ToPro (blue). Representative images
are shown for three coronal sections from 4 mice in two separate
experiments. IC isotype control. Scale bars 10 lm. The area of
GFAP? (i) or NG2? (l) cells in wild-type mice after 6 (white bars)
and 12 (black bars) weeks of CPZ exposure was quantified, n = 6
images taken from 4 mice/group. *P \ 0.05. Engraftment of astro-
cytes infected with CXCL12-encoding lentivirus rescues
remyelination following chronic demyelination. Wild-type mice were
fed a diet containing 0.2 % CPZ for 12 weeks and then the CC were
injected with cultured astrocytes infected with mCherry-expressing
lentiviruses encoding empty vector and CXCL12 protein. Quantita-
tive confocal IHC was used to analyze the CC 10 days after the
cessation of CPZ and stereotactic injections. Images depict immuno-
detection of mCherry expression (red) with staining for (m, n) MBP
(green). Nuclei are counterstained with ToPro (blue). The intensity of
MBP expression/area of GFAP? mCherry? (o) within the CC of
demyelinated mice (black bars) was quantified. Representative
images are shown for three coronal sections from 5 mice/group.
Scale bars 10 lm
b
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chemokines such as CXCL1 and/or CXCL2. Studies have
demonstrated that CXCR2, the receptor for CXCL1 and
CXCL2, is expressed by OPCs and oligodendrocytes [29]
and has been shown to direct OPC positioning during
spinal cord development [52]. TNFa has been shown to
induce CXCL1 and CXCL2 in cultured mouse astrocytes
and stereotaxic injection of TNF-a to the SJL and BALBc
mouse brains induced CXCL2 [18, 42, 55]. Given that we
found attenuated CXCL1 message in the TNFR2 deficient
mice and decreased numbers of OPCs within the CC,
these data suggest that TNFR2 signaling may mediate
migration of OPCs via CXCL1 signaling. However, further
experiments are necessary to determine the individual
contributions of TNFa/TNFR2, CXCL12/CXCR4, and
CXCL1/CXCR2 in regulating remyelination.
Other published studies have reported that CXCR4 plays
an important role in all aspects of oligodendrocyte biology,
including migration. Cultured neonatal OPCs respond to
CXCL12 via directed chemotaxis and both CXCR4 and
CXCR7, a non-signaling CXCL12 receptor, influence OPC
maturation [14, 19]. In in vivo studies, however, Carbajal
et al. [10] reported that CXCR4, but not CXCR7, plays a
role in the migration and differentiation of OPCs in a model
of chronic demyelination within the spinal cord after pri-
mary infection with mouse hepatitis virus (MHV) [11].
Furthermore, in follow-up studies, CXCR4 antagonism was
shown to inhibit endogenous OPC maturation and increased
the rate of proliferation in the MHV viral model [10]. In the
EAE model, Olig2-EGFP? or CXCR4-EGFP? oligoden-
drocyte progenitors implanted into the lateral ventricles of
mice at peak of disease migrated into the CC in response to
elevated CXCL12 levels and differentiated into mature ol-
igodendrocytes [3]. In addition, migration was inhibited
after RNA silencing of CXCR4 [3]. Taken together these
reports demonstrate that CXCL12/CXCR4 are important
players in mediating OPC biology and an alteration in
expression levels of CXCL12 or CXCR4 influences
remyelination.
Our results show that TNFR2 deficient mice have
reduced CXCL12 expression by astrocytes after CPZ-
induced demyelination and that this correlates with reduced
OPC numbers. Under normal conditions, astrocytes are a
major cellular component of the CNS that provide meta-
bolic and trophic support to maintain homeostasis [49, 53],
however, the role of astrogliosis in CNS repair remains
controversial. The presence of reactive astrocytes in areas
of demyelination has been observed to decrease remyeli-
nation within the spinal cord after transplantation of OPCs
[7]. In addition, astrocytes isolated from contused spinal
cord inhibited the in vitro differentiation of OPCs, whereas
astrocytes derived from normal spinal cord did not [54].
However, in several demyelinating models, including cu-
prizone and EAE, proliferating astrocytes and their secreted
factors can promote remyelination in both the spinal cord
and CC [16, 38, 39, 43]. Consistent with this, expression of
CXCL12 by activated astrocytes within the acutely
demyelinated CC influences remyelination by mediating
the proliferation and differentiation of OPCs. Reduced
astrocyte activation or numbers in the chronically demye-




CXCR4, astrocytes and OPCs
interact in the context of
remyelination. In the CPZ
model, ingestion of the copper
chelator leads to complete
demyelination of the CC via
apoptosis of oligodendrocytes.
This causes the activation of
microglia and astrocytes that
express both TNFR1 and
TNFR2. Microglia and
astrocytes produce TNF-a. On
astrocytes, the activation of
TNFR2 induces CXCL12
expression. In turn, CXCL12
activates CXCR4, which is
expressed by OPCs. Activation
of CXCR4 causes the
proliferation of OPCs and
differentiation into myelinating
oligodendrocytes
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differentiation and functional myelin formation through
loss of a proliferative or trophic microenvironment.
Alterations in astrocyte activity may also have an impact
on the success of treatments that attempt to augment or
enhance remyelination in MS patients. Lentiviral vectors,
for example, are able to preferentially transduce major glial
cell types within white matter, such as astrocytes [57]. In
our study, CXCL12-encoding lentivirus promoted OPC
proliferation and remyelination within the demyelinated
CC of TNFR2-deficient mice, which exhibit large numbers
of activated astrocytes, but not in the CC of chronically
demyelinated mice, which exhibit astrocyte depletion. In
addition, as OPC numbers are also reduced during pro-
longed CPZ treatment, reinstating CXCL12 may exert little
effect on their proliferative capacity and ultimate ability to
remyelinate. However, further studies are necessary since
restoration of depleted OPC and astrocyte populations may
require more time to show sufficient remyelination after
chronic demyelination. Given the role of CXCL1 on OPC
recruitment, lentiviruses expressing multiple chemokines
might be required to promote OPC recruitment, prolifera-
tion and differentiation within MS lesions. In addition, ex
vivo gene therapy, in which cells are genetically modified
prior to implantation into the brain, might be employed to
replenish depleted astrocytes that augment repair signals
[20]. In our study, CXCL12-expressing astrocytes engraf-
ted into the CC of chronically demyelinated showed an
increase in myelin expression suggesting that remyelina-
tion may be rescued with chemokines and cells that
influence chemokine expression in the brain. Such gene
therapy or stem cell engraftment approaches may enable
the localized manipulation of factors to induce remyeli-
nation within various types of MS lesions.
In summary, our data indicate that TNFR2 signaling by
activated astrocytes within the demyelinated adult CNS is
essential for their expression of CXCL12, which facilitates
OPC proliferation and myelin repair. Lentiviral vector-
based gene delivery of CXCL12 improved remyelination
specifically where loss of astrocytes or OPCs did not pre-
vent lentiviral or CXCL12 targeting. These studies enhance
our understanding of cytokine-mediated recovery from
demyelination and demonstrate that reinstating chemokine
expression may be a feasible approach for the treatment
of MS.
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